Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of DNA.HIVA and MVA.HIVA Prime-Boost Vaccine
NCT01371175Phase 2Completed
- Sponsor
- International AIDS Vaccine Initiative
- Start
- Apr 2003
- Primary completion
- May 2005
- Modality
- Prophylactic Vaccines, Viral Vectors, DNA Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of DNA.HIVA, MVA.HIVA in human immunodeficiency virus infection (HIV), sponsored by International AIDS Vaccine Initiative. Started Apr 2003; status: completed.
02
Drugs
DNA.HIVAMVA.HIVA
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01371175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371175.